Futran ND - Search Results

1

Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline.

Peterson DE, Koyfman SA, Yarom N, Lynggaard CD, Ismaila N, Forner LE, Fuller CD, Mowery YM, Murphy BA, Watson E, Yang DH, Alajbeg I, Bossi P, Fritz M, Futran ND, Gelblum DY, King E, Ruggiero S, Smith DK, Villa A, Wu JS, Saunders D. Peterson DE, et al. Among authors: futran nd. J Clin Oncol. 2024 Jun 1;42(16):1975-1996. doi: 10.1200/JCO.23.02750. Epub 2024 May 1. J Clin Oncol. 2024. PMID: 38691821

2

Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO Guideline Clinical Insights.

Saunders D, Koyfman SA, Ismaila N, Futran ND, Mowery YM, Watson E, Yang DH, Peterson DE. Saunders D, et al. Among authors: futran nd. JCO Oncol Pract. 2024 Dec;20(12):1571-1574. doi: 10.1200/OP.24.00182. Epub 2024 May 1. JCO Oncol Pract. 2024. PMID: 38691818 No abstract available.

3

Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Pan C, Ng K, Voutsinas J, Barber B, Rizvi ZH, Marchiano E, Ferrandino RM, Futran N, Laramore GE, Liao JJ, Parvathaneni U, Panjwani N, Martins RG, Rodriguez CP, Wu QV. Pan C, et al. BMC Cancer. 2024 Nov 15;24(1):1406. doi: 10.1186/s12885-024-13051-6. BMC Cancer. 2024. PMID: 39543541 Free PMC article.

4

Peripheral lymphocytes and lactate dehydrogenase correlate with response and survival in head and neck cancers treated with immune checkpoint inhibitors.

Pan C, Wu QV, Voutsinas J, Houlton JJ, Barber B, Rizvi ZH, Marchiano E, Futran N, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Fromm JR, Rodriguez CP. Pan C, et al. Cancer Med. 2023 Apr;12(8):9384-9391. doi: 10.1002/cam4.5697. Epub 2023 Feb 21. Cancer Med. 2023. PMID: 36806947 Free PMC article.

5

Clarification of the margin status by the multidisciplinary tumor board following transoral robotic surgery for p16 positive oropharyngeal squamous cell carcinoma.

Parvathaneni A, Patel SA, Houlton JJ, Pang J, Futran ND. Parvathaneni A, et al. Among authors: futran nd. Laryngoscope Investig Otolaryngol. 2023 Oct 6;8(6):1500-1506. doi: 10.1002/lio2.1163. eCollection 2023 Dec. Laryngoscope Investig Otolaryngol. 2023. PMID: 38130253 Free PMC article.

6

Primary thyroid hemangioma, a rare diagnosis in a patient with a painless neck mass.

Seuferling J, Diaz A, Futran N, Bandhlish A, Wangaryattawanich P. Seuferling J, et al. Radiol Case Rep. 2022 Nov 24;18(2):519-523. doi: 10.1016/j.radcr.2022.10.093. eCollection 2023 Feb. Radiol Case Rep. 2022. PMID: 36439915 Free PMC article.

7

Radiation therapy for low- and high-risk perineural invasion in head and neck cutaneous squamous cell carcinoma: Clinical outcomes and patterns of failure.

Gobillot TA, Greer M, Parvathaneni U, Liao JJ, Laramore GE, Goff P, Wallner K, Rodriguez CP, Houlton JJ, Barber BR, Futran ND, Rizvi ZH. Gobillot TA, et al. Among authors: futran nd. Head Neck. 2023 Sep;45(9):2323-2334. doi: 10.1002/hed.27458. Epub 2023 Jul 14. Head Neck. 2023. PMID: 37448346

8

Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.

Konuthula N, Do OA, Gobillot T, Rodriguez CP, Futran ND, Houlton J, Barber BR. Konuthula N, et al. Among authors: futran nd. Head Neck. 2022 Nov;44(11):2465-2472. doi: 10.1002/hed.27162. Epub 2022 Aug 5. Head Neck. 2022. PMID: 35930296

9

Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent/metastatic head and neck cancer (RMHNSCC) patients.

Chalker C, Voutsinas JM, Wu QV, Santana-Davila R, Hwang V, Baik CS, Lee S, Barber B, Futran ND, Houlton JJ, Laramore GE, Liao JJ, Parvathaneni U, Martins RG, Eaton KD, Rodriguez CP. Chalker C, et al. Among authors: futran nd. Cancer Med. 2022 Nov;11(22):4104-4111. doi: 10.1002/cam4.4722. Epub 2022 Mar 29. Cancer Med. 2022. PMID: 35349227 Free PMC article.

10

Impact of HPV status on immune responses in head and neck squamous cell carcinoma.

Qureshi HA, Zhu X, Yang GH, Steadele M, Pierce RH, Futran ND, Lee SM, Méndez E, Houghton AM. Qureshi HA, et al. Among authors: futran nd. Oral Oncol. 2022 Apr;127:105774. doi: 10.1016/j.oraloncology.2022.105774. Epub 2022 Feb 24. Oral Oncol. 2022. PMID: 35219073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters